ProMab Biotechnologies, established in 2001, is a leading brand that specializes in the development and commercialization of recombinant proteins, antibodies, and engineered cell lines. By utilizing cutting-edge technologies and expertise in bioinformatics, molecular biology, protein expression, and gene cloning, ProMab provides innovative research and diagnostic products to the global biomedical research community. ProMab offers a wide range of products and services, including primary antibodies, full-length proteins, CAR-T/CAR-NK products, and hematological cell products.

They also provide custom antibody engineering services, engineered cell line and CAR-T/CAR-NK services, and protein expression services. Furthermore, ProMab has developed a unique mRNA lipid nanoparticle (mRNA-LNP) platform, offering ready-to-use reagents and custom research services for various fields of research. With a focus on immunotherapy, particularly CAR-T/NK cell technologies, ProMab is committed to improving human health.

Their extensive experience in generating highly specific monoclonal antibodies has positioned them as a pioneer in CAR-T development, making them the world's first CAR-T CRO. Discover ProMab Biotechnologies' exceptional products, services, and advancements in the field of immunotherapy to accelerate your research and diagnostic goals